Deep anterior lamellar keratoplasty in herpes simplex corneal opacities

Cornea

Volumn 29, Issue 1, 2010, Pages 60-64

  Sarnicola, Vincenzo ^a   Toro, Patricia ^a  

^a MISERICORDIA HOSPITAL   (Italy)

Author keywords

Corneal scars; Deep anterior lamellar keratoplasty; Herpetic stromal keratitis

Indexed keywords

ACICLOVIR; ANTIVIRUS AGENT; CORTICOSTEROID DERIVATIVE; DEXAMETHASONE;

ADULT; ARTICLE; CELL COUNT; CELL LOSS; CONTROLLED STUDY; CORNEA OPACITY; DESCEMET MEMBRANE; ENDOTHELIUM CELL; FEMALE; HERPES SIMPLEX KERATITIS; HUMAN; KERATOPLASTY; MAJOR CLINICAL STUDY; MALE; PENETRATING KERATOPLASTY; PRIORITY JOURNAL; RECURRENT DISEASE; SPECTACLES; VISUAL ACUITY; ANTERIOR EYE SEGMENT; CORNEA ENDOTHELIUM; CORNEA TRANSPLANTATION; FOLLOW UP; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; TREATMENT OUTCOME;

ADULT; ANTERIOR EYE SEGMENT; CELL COUNT; CORNEAL OPACITY; CORNEAL TRANSPLANTATION; DESCEMET MEMBRANE; ENDOTHELIUM, CORNEAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; KERATITIS, HERPETIC; MALE; MIDDLE AGED; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 75649099425     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/ICO.0b013e3181a317d3     Document Type: Article

References (40)

1. Stevens JG, Cook ML. Latent herpes simplex virus in spinal ganglia of mice. Science. 1971;173:843-845.
2. Whitley RJ. Herpes simplex viruses. In Howley DKP. Fields Virology, 4th edition, pp. 2461-2509. Philadelphia: Lippincott Williams & Wilkins; 2001.
3. Holland EJ, Schwartz GS. Classification of herpes simplex virus keratitis. Cornea. 1999;18:144-154.
4. Deshpande S, Banerjee K, Biswas PS, et al. Herpetic eye disease: immunopathogenesis and therapeutic measures. Expert Rev Mol Med. 2004;2004:1-14.
5. Deshpande SP, Zheng M, Lee S, Rouse BT. Mechanisms of pathogenesis in herpetic immunoinflammatory ocular lesions. Vet Microbiol. 2002;86: 17-26.
6. Streilein JW, Dana MR, Ksander BR. Immunity causing blindness: five different paths to herpes stromal keratitis. Immunol Today. 1997;18: 443-449.
7. Avery AC, Zhao ZS, Rodriguez A, et al. Resistance to herpes stromal keratitis conferred by an IgG2a-derived peptide. Nature. 1995;376: 431-434.
8. Zhao ZS, Granucci F, Yeh L, et al. Molecular mimicry by herpes simplex virus-type 1: autoimmune disease after viral infection. Science 1998;279:1344-1347.
9. Deshpande S, Zheng M, Lee S, et al. Bystander activation involving T lymphocytes in herpetic stromal keratitis. J Immunol. 2001;167: 2902-2910.
10. Cantin E, Chen J, Willey DE, et al. Persistence of herpes simplex virus DNA in rabbit corneal cells. Invest Ophthalmol Vis Sci. 1992;33: 2470-2475.
11. Polcicova K, Biswas PS, Banerjee K, et al. Herpes keratitis in the absence of anterograde transport of virus from sensory ganglia to the cornea. Proc Natl Acad Sci U S A. 2005;102:11462-11467.
12. Morishige N, Jester JV, Naito J, et al. Herpes simplex virus type 1 ICP0 localizes in the stromal layer of infected rabbit corneas and resides predominantly in the cytoplasm and/or perinuclear region of rabbit keratocytes. J Gen Virol. 2006;87:2817-2825
13. Anwar M, Teichmann KD. Big-bubble technique to bare Descemet's membrane in anterior lamellar keratoplasty. J Cataract Refract Surg. 2002;28:398-403.
14. Epstein RJ, Seedor JA, Dreizen NG, et al. Penetrating keratoplasty for herpes simplex keratitis and keratoconus: Allograft rejection and survival. Ophthalmology. 1987;94:935-944.
15. Ficker LA, Kirkness CM, Rice NSC, et al. Longterm prognosis for corneal grafting in herpes simplex keratitis. Eye. 1988;2:400-408.
16. Nicholls SM, Shimeld C, Easty DL, Hill TJ. Recurrent herpes simplex after corneal transplantation in rats. Invest Ophthalmol Vis Sci. 1996;37: 425-435.
17. Lomholt JA, Baggesen K, Ehlers N. Recurrence and rejection rates following corneal transplantation for herpes simplex keratitis. Acta Ophthalmol Scand. 1995;73:29-32.
18. Mannis MJ, Plotnik RD, Schwab IR, et al. Herpes simplex dendritic keratitis after keratoplasty. Am J Ophthalmol 1991;111:140-484.
19. Biswas S, Suresh P, Bonshek RE, et al. Graft failure in human donor corneas due to transmission of herpes simplex virus. Br J Ophthalmol. 2000;84:701-705.
20. Cockerham GC, Krafft AE, McLean IW. Herpes simplex primary in graft failure. Arch Ophthalmol. 1997;115:586-589.
21. De Kessel RJ, Koppen C, Ieven M, et al. Primary graft failure caused by herpes simplex virus type 1. Cornea. 2001;20:187-190.
22. Remeijer L, Maertzdorf J, Doorneubal P, et al. Herpes simplex virus 1 transmission through corneal transplantation. Lancet. 2001;357:442.
23. Thompson RW Jr, Price MO, Bowers PJ, et al. Long-term graft survival after penetrating keratoplasty. Ophthalmology. 2003;110:1396-1402.
24. Ficker LA, Kirkness CM, Rice NSC, et al. The changing management and improved prognosis for corneal grafting in herpes simplex keratitis. Ophthalmology. 1989;96:1587-1596.
25. Cohen EJ, Laibson PR, Arentsen JJ. Corneal transplantation for herpes simplex keratitis. Am J Ophthalmol. 1983;95:645-650.
26. Cobo LM, Coster DJ, Rice NSC, et al. Prognosis and management of corneal transplantation for herpetic keratitis. Arch Ophthalmol. 1980;98: 1755-1759.
27. Barney N, Foster CS. A prospective randomized trial of oral acyclovir after penetrating keratoplasty for herpes simplex keratitis. Cornea. 1994; 13:232-236.
28. Hung SO, Patterson A, Rees PJ. Oral acyclovir in the management of dendritic herpetic corneal ulceration. Br J Ophthalmol. 1984;68:398.
29. Spruance SL, Stewart JC, Rowe NH, et al. Treatment of recurrent herpes simplex labialis with oral acyclovir. J Infect Dis. 1990;161:185.
30. Kaplowitz LG, Baker D, Gelb L. Prolonged continuous acyclovir treatment of normal adults with frequently recurring genital herpes simplex virus infection. JAMA. 1991;265:747.
31. Herpetic Eye Disease Study Group. A controlled trial of oral acyclovir for the prevention of stromal keratitis or iritis in patients with herpes simplex virus epithelial keratitis [published correction appears in Arch Ophthalmol. 1997;115:1196]. Arch Ophthalmol. 1997;115: 703-712.
32. The Herpetic Eye Disease Study Group. Acyclovir for the prevention of recurrent herpes simplex virus eye disease. N Engl J Med. 1998;339: 300-306.
33. Alldredge OC, Krachmer JH. Clinical types of corneal transplant rejection. Their manifestations, frequency, preoperative correlates, and treatment. Arch Ophthalmol. 1981;99:599-604.
34. Al-Torbak A,MalakM, Teichmann KD, et al. Presumed stromal graft rejection after deep anterior lamellar keratoplasty. Cornea. 2005;24:241-243.
35. Ing JJ, Ing HH, Nelson JR, et al. Ten-year postoperative results of penetrating keratoplasty. Ophthalmology. 1998;105:1855-1865.
36. Shimazaki J, Shimmura S, Ishioka M, et al. Randomized clinical trial of deep lamellar keratoplasty Vs penetrating keratoplasty. Am J Ophthalmol. 2002;134:159-165.
37. Vajpayee RB, Tyagi J, Sharma N, et al. Deep anterior lamellar keratoplasty by big-bubble technique for treatment corneal stromal opacities. Am J Ophthalmol. 2007;143:954-957.
38. Fogla R, Padmanabhan P. results of deep lamellar keratoplasty using the big-bubble technique in patients with keratoconus. Am J Ophthalmol. 2006;141:254-259.
39. Watson SL, Ramsay A, Dart JKG, et al. Comparison of deep lamellar keratoplasty and penetrating keratoplasty in patients with keratoconus. Ophthalmology. 2004;111:1676-1682.
40. Sarnicola V, Toro P, Conti L, et al. Descemetic DALK (dDALK) and predescemetic DALK (pdDALK): outcomes in 236 cases of keratoconus. Cornea. 2009; In press.